Artax Biopharma Inc Is A Clinical Stage Biotechnology Company Based In Massachusettsthe Company Focuses On Developing Innovative Immunomodulatory Therapies For T Cell Driven Autoimmune And Inflammatory Diseaseswith A Team Of 11Ae 50 Professionalsartax Is Dedicated To Restoring Immune Balance Without Causing Systemic Immunosuppression One Of Their Key Products Is Ax 158An Oral Small Molecule Nck Modulator Currently In Clinical Trials For Autoimmune Diseasesthe Company Is Conducting Phase 2A Trialswith Results Expected In Late 2024And Plans To Explore Its Efficacy In Conditions Like Psoriasis And Atopic Dermatitisartax S Approach Targets The T Cell Receptortcrsignaling Pathwayaiming To Provide Effective Treatment Options For Patients Who Do Not Respond To Existing Therapies Artax Is Led By A Team Of Experienced Professionalsincluding Ceo Rob Armstrongph D And Supported By A Scientific Advisory Boardthe Company Recently Raised $8 Million To Further Its Clinical Programs And Is Committed To Advancing Treatments That Maintain Immune Functionality While Managing Disease Activity
